ALAMEDA, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Xenogen Corporation
(Nasdaq: XGEN) today announced that it will release 2005 third quarter
financial results after the close of market on Thursday, November 3, 2005.
Shortly after the news release is issued, Xenogen's management will host a
conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
What: Xenogen (Nasdaq: XGEN) will release 2005 third quarter results,
followed by a teleconference.
When: Teleconference begins on Thursday, November 3 at 5:00 p.m. ET
(2:00 p.m. PT).
Who: David Carter, Chief Executive Officer and Chairman; Dr. Pamela
Contag, President; William Albright, Chief Financial Officer.
How: Dial 800-475-3716 (domestic) or 719-457-2728 (international) to
listen to the call. A live webcast also will be made available
at http://www.xenogen.com.
A phone replay will be available for 48 hours following the completion of
the call by dialing 888-203-1112 (domestic) or 719-457-0820 (international),
and entering in reservation code 251-4643. The webcast will be archived and
available on the Xenogen website for 14 days.
About Xenogen Corporation
Xenogen Corporation is a leading biotechnology company offering an
integrated suite of biophotonic real-time in vivo imaging and genetic
modification technologies that can help expedite drug discovery and
development, and significantly reduce the cost and time to market for new
therapies. Xenogen's VivoVision(TM) Systems non-invasively illuminate and
monitor biological processes within living mammals, at the molecular level, in
real time. The technology provides higher quality in vivo data earlier in the
drug discovery and development process. VivoVision(TM) Solutions improve
discovery and pre-clinical research in multiple therapeutic areas.
VivoVision(TM) Biosciences represents more than 15 years of experience in the
creation and characterization of animal models, including genetic
modifications, comprehensive phenotyping, compound profiling and custom design
and production of light producing cells, microorganisms and animals.
More information is available at http://www.xenogen.com. Xenogen(R), Living
Image(R), VivoVision(TM) and IVIS(R) are trademarks of Xenogen Corporation.
SOURCE Xenogen Corporation
 back to top
Related links:
http://www.xenogen.com
CONTACT:
William A. Albright, Chief Financial Officer
of Xenogen Corporation, +1-510-291-6104; or investors, Jim Byers
of Financial Dynamics, +1-415-439-4504; or media, Kelly O'Brien
of Manning Selvage & Lee, +1-415-364-3840, both of Xenogen
Corporation
|
